OpGen, Inc. (OPGN): Price and Financial Metrics
OPGN Price/Volume Stats
Current price | $0.49 | 52-week high | $3.84 |
Prev. close | $0.48 | 52-week low | $0.17 |
Day low | $0.45 | Volume | 162,900 |
Day high | $0.50 | Avg. volume | 198,275 |
50-day MA | $0.42 | Dividend yield | N/A |
200-day MA | $0.48 | Market Cap | 4.86M |
OPGN Stock Price Chart Interactive Chart >
OPGN Stock Summary
- OPGN has a market capitalization of $4,155,612 -- more than approximately just 2.23% of US stocks.
- The volatility of OPGEN INC's share price is greater than that of 92.75% US stocks with at least 200 days of trading history.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for OPGN comes in at -175.35% -- higher than that of just 2.53% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to OPGEN INC are EMKR, AGCO, TWOU, ACIW, and INPX.
- Visit OPGN's SEC page to see the company's official filings. To visit the company's web site, go to www.opgen.com.
OPGN Valuation Summary
- In comparison to the median Healthcare stock, OPGN's EV/EBIT ratio is 104.79% lower, now standing at -0.7.
- Over the past 105 months, OPGN's price/earnings ratio has gone up 8.1.
Below are key valuation metrics over time for OPGN.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
OPGN | 2023-12-29 | 1.4 | 1.6 | -0.2 | -0.7 |
OPGN | 2023-12-28 | 1.4 | 1.6 | -0.2 | -0.7 |
OPGN | 2023-12-27 | 1.4 | 1.6 | -0.2 | -0.7 |
OPGN | 2023-12-26 | 1.4 | 1.6 | -0.2 | -0.7 |
OPGN | 2023-12-22 | 1.4 | 1.6 | -0.2 | -0.7 |
OPGN | 2023-12-21 | 1.4 | 1.6 | -0.2 | -0.7 |
OPGN Growth Metrics
- Its 5 year price growth rate is now at -99.58%.
- Its 4 year cash and equivalents growth rate is now at 586.67%.
- Its 3 year revenue growth rate is now at 26.47%.
The table below shows OPGN's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 3.311231 | -20.24373 | -40.72673 |
2022-06-30 | 4.10165 | -20.62097 | -32.67944 |
2022-03-31 | 3.94606 | -21.55475 | -33.92559 |
2021-12-31 | 4.306031 | -21.47928 | -41.97246 |
2021-09-30 | 4.232821 | -24.62876 | -35.10417 |
2021-06-30 | 4.050454 | -26.723 | -36.72306 |
OPGN's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- OPGN has a Quality Grade of D, ranking ahead of 6.34% of graded US stocks.
- OPGN's asset turnover comes in at 0.068 -- ranking 75th of 81 Healthcare stocks.
- PMD, MGLN, and THC are the stocks whose asset turnover ratios are most correlated with OPGN.
The table below shows OPGN's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.068 | 0.109 | -1.125 |
2021-03-31 | 0.082 | 0.075 | -1.281 |
2020-12-31 | 0.105 | 0.087 | -1.177 |
2020-09-30 | 0.122 | 0.118 | -1.429 |
2020-06-30 | 0.158 | 0.329 | -1.982 |
2020-03-31 | 0.272 | 0.457 | -3.454 |
OPGN Price Target
For more insight on analysts targets of OPGN, see our OPGN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $5.00 | Average Broker Recommendation | 1.5 (Moderate Buy) |
Latest OPGN News From Around the Web
Below are the latest news stories about OPGEN INC that investors may wish to consider to help them evaluate OPGN as an investment opportunity.
OpGen Reports Third Quarter 2023 Financial Results and Provides Business UpdateTotal revenue for the first nine months of 2023 was approximately $2.35 million compared to approximately $1.89 million in the first nine months of 2022Implemented certain cash management initiatives, including restructuring U.S. operations by reducing headcount during the third quarter of 2023Signed preferred stock purchase agreement with a potential strategic investor in October 2023Entered into a warrant inducement agreement with an institutional investor in October 2023Subsidiaries Curetis G |
Why Is OpGen (OPGN) Stock Up 540% Today?OpGen stock is undergoing a massive rally on Thursday following as OPGN investors react to two pieces of news from the company! |
Why Is Phio Pharma (PHIO) Stock Down 35% Today?Phio Pharma stock is pulling back on Thursday after shares of PHIO underwent a massive rally on Wednesday with a preclinical trial update. |
Why Is Secoo (SECO) Stock Up 703% Today?Secoo stock is experiencing a massive rally on Thursday with heavy trading of SECO shares despite a lack of news from the company. |
Why Is Tempest Therapeutics (TPST) Stock Down 35% Today?Tempest Therapeutics stock is taking a beating on Thursday as shares of TPST retreat from a massive rally yesterday on clinical trial news! |
OPGN Price Returns
1-mo | 7.69% |
3-mo | 16.11% |
6-mo | 117.78% |
1-year | -68.39% |
3-year | -99.17% |
5-year | -99.88% |
YTD | 16.67% |
2023 | -85.11% |
2022 | -85.90% |
2021 | -50.98% |
2020 | 80.53% |
2019 | -95.65% |
Continue Researching OPGN
Want to see what other sources are saying about Opgen Inc's financials and stock price? Try the links below:Opgen Inc (OPGN) Stock Price | Nasdaq
Opgen Inc (OPGN) Stock Quote, History and News - Yahoo Finance
Opgen Inc (OPGN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...